ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,546Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 823

$948K Total Retail Price of All Prescriptions

Rank: 25 out of 823

1,169 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,169 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

12% of this provider’s 1,169 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 8,715 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 600 484 1 2
LISINOPRIL 550 435 2 4
METFORMIN HCL 451 337 3 14
LEVOTHYROXINE SODIUM 357 321 4 6
HYDROCODONE-ACETAMINOPHEN 351 258 S3 5 1
AMLODIPINE BESYLATE 329 281 6 3
OMEPRAZOLE 327 275 7 5
METOPROLOL TARTRATE 238 199 8 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 238 191 8 39
FUROSEMIDE 204 141 10 7
MELOXICAM 198 175 11 27
NEXIUM 175 130 12 10
TRAMADOL HCL 170 103 13 15
ALENDRONATE SODIUM 164 137 14 42
IBUPROFEN 154 82 15 103
GLIPIZIDE 143 116 16 105
ZOLPIDEM TARTRATE 142 110 17 17
AMLODIPINE BESYLATE-BENAZEPRIL 136 133 18 81
CRESTOR 136 84 18 20
WARFARIN SODIUM 119 83 20 18
TAMSULOSIN HCL 114 94 21 21
METOPROLOL SUCCINATE 114 94 21 9
ATORVASTATIN CALCIUM 111 76 23 13
HYDROCHLOROTHIAZIDE 102 88 24 29
LOSARTAN POTASSIUM 93 67 25 26
GLYBURIDE-METFORMIN HCL 88 75 R 26 121
JANUVIA 86 47 27 70
INSULIN SYRINGE 85 42 28 125
GABAPENTIN 84 60 29 8
ACTOS 84 71 29 130
LANTUS 83 54 31 76
LOSARTAN-HYDROCHLOROTHIAZIDE 83 67 31 57
GLIPIZIDE ER 81 69 33 229
CARVEDILOL 80 56 34 12
AZITHROMYCIN 77 58 35 48
ACTOPLUS MET 76 42 36 310
GEMFIBROZIL 76 59 36 235
SERTRALINE HCL 75 69 38 38
DONEPEZIL HCL 75 69 38 24
ALLOPURINOL 74 48 40 61
CLOPIDOGREL 71 64 41 16
CIPROFLOXACIN HCL 71 60 41 32
SPIRONOLACTONE 70 49 43 72
PREDNISONE 68 60 44 31
LEVEMIR FLEXPEN 63 28 45 221
ATENOLOL 62 43 46 47
CYMBALTA 61 46 47 40
PANTOPRAZOLE SODIUM 61 30 47 30
NAPROXEN 61 37 47 93
NATEGLINIDE 60 21 50 289
POTASSIUM CHLORIDE 58 42 51 22
PRAVASTATIN SODIUM 56 49 52 23
CLONIDINE HCL 53 47 53 41
MECLIZINE HCL 53 45 53 184
RANITIDINE HCL 52 47 55 74
PLAVIX 50 50 56 25
LIPITOR 50 32 56 128
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.